ABVC BioPharma, Inc. (ABVC)

1.0800 0.0000 (0.00%) At close: 04:00PM EDT

ABVC BioPharma, Inc.

44370 Old Warm Springs Boulevard
Fremont, CA 94538
United States
(510)-668-0881
https://www.abvcpharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 16

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Eugene Jiang	Chairman & Chief Business Officer	200k	N/A	1986
Dr. Uttam Yashwant Patil Ph.D.	Chief Executive Officer	N/A	N/A	1986
Mr. Leeds Chow	CFO & Principal Accounting Officer	180k	N/A	1989
Dr. Tsung-Shann Jiang EMBA, Ph.D.	Chief Scientific Officer, Chief Strategy Officer & Director	200k	N/A	1954

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

Corporate governance

ABVC BioPharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.